Chalcones have been widely researched its activity as anticancer. The substitution of the functional groups on the chalcones structure affects its anticancer activity. The objective of this research were to investigate the cytotoxic effects of bromo chalcone [1-(4’-bromophenyl)-3-(4-hydroxy-3-methoxyphenyl)-2-propene-1-on] or BHM on T47D breast cancer cells by invitro, and to analyze its effect on cell apoptosis. Cytotoxic activity of BHM on T47D cells was assayed by MTT (3-[4, 5-dimethylthiazol-2-yl)-2, 5 diphenyl tetrazolium bromide] method, while the effect of apoptosis was analyzed using flowcytometer. Furthermore, the apoptotic mechanism was traced by observing the expression of Bcl-2 protein using immunocytochemistry. The results indicated that BHM have cytotoxic effect on T47D cells (IC50 = 45 micro molar). The activity occurs because these compounds induce apoptosis by decreasing the expression of Bcl-2. According to the results, BHM could potentially be developed as a new drug candidate for breast cancer therapy.

1.
American Cancer Society
,
Cancer Facts & Figures
, (
Atlanta
:
American Cancer Society
,
2012
), pp
9
.
2.
D.
Tjindarbumi
and
R.
Mangunkusumo
,
Jpn. J. Clin. Oncol.
32
(Supplement
1
):
S17
21
(
2002
).
3.
R.J.B.
King
, “
Cancer Biology
”,
Pearson Education.
Second Edition,
England
, (
2000
), pp.1-7, 228-231,
263
264
.
4.
L.F.
Motta
,
A.C.
Gaudio
and
Y.
Takahata
,
Internet Electronic Journal of Molecular Design
,
5
,
55
569
(
2006
).
5.
M.A.
Rahman
,
Chemical Sciences Journal
,
29
,
1
6
(
2011
).
6.
G.
Achanta
,
A.
Modzelewska
,
L.
Feng
,
S.R.
Khan
and
P.
Huang
,
Molecular Pharmacology
,
70
,
426
433
(
2006
).
7.
R.
Romagnoli
,
P.G.
Baraldi
,
M.D.
Carrion
,
C. L.
Cara
,
O.
Cruz-Lopez
and
D.
Preti
,
Bioorganic and Medicinal Chemistry
,
16
,
5367
5376
(
2008
).
8.
C.
Echeverria
,
J.F.
Santibanez
,
O.
Donoso-Tauda
,
C.A.
Escobar
and
R.R.
Tagle
,
International Journal of Molecular Sciences
,
10
,
221
231
(
2009
).
9.
E.
Szliszka
,
Z.P.
Czuba
,
B.
Mazur
,
L.
Sedek
,
A.
Paradysz
and
W.
Krol
,
International Journal of Molecular Sciences
,
11
,
1
13
(
2010
).
10.
K.
Ilango
,
P.
Valentina
and
G.
Saluja
,
Research Journal of Pharmaceutical, Biological and Chemical Sciences
,
1
:
354
359
(
2010
)
11.
N.Y.
Kim
,
H.O.
Pae
,
G.S.
Oh
,
T.H.
Kang
,
Y.C.
Kim
and
H.Y.
Rhew
,
Pharmacol Toxicol
,
88
,
261
6
(
2001
).
12.
C.L.
Ye
,
F.
Qian
,
D.Z.
Wei
,
Y.H.
Lu
and
J.W.
Liu
,
Leuk Res.
,
29
,
887
92
(
2005
).
13.
Y.L.
Hsu
,
P.L.
Kuo
,
W.S.
Tzeng
and
C.C.
Lin
,
Food and Chemical Toxicology : an international journal published for the British Industrial Biological Research Association
,
44
(
5
):
704
13
(
2006
).
14.
K.H.
Shen
,
J.K.
Chang
,
Y.L.
Hsu
and
P.L.
Kuo
,
Basic Clin Pharmacol Toxicol
,
101
,
254
61
(
2007
).
15.
I. S.
Arty
,
Indo J. Chem
,
10
(
1
),
110
115
(
2010
).
16.
R.
Arianingrum
,
R.
Sunarminingsih
,
E.
Meiyanto
and
S.
Mubarika
, “
Potential of a chalcone derivate compound as cancer chemoprevention in breast cancer
”, in
3rd International Conference on Chemistry and Chemical Engineerin, IPCBEE
,
38
,
41
45
(
2012
),
IACSIT Press
,
Singapore
.
17.
R.
Arianingrum
,
R.
Sunarminingsih
,
E.
Meiyanto
and
S.
Mubarika
, “
Cytotoxic effect of para hydroxyl chalcone (pHmMC) on MCF-7 breast cancer cells by inducing cell arrest and apoptosis
”,
2ndICRIEMS proceedings, C-11:89-95 (2015
),
Universitas Negeri Yogyakarta
,
Indonesia
.
18.
R.
Arianingrum
,
R.
Sunarminingsih
,
E.
Meiyanto
and
S.
Mubarika
,
International Journal of Pharmaceutical and Clinical Research
,
8
(
5
)Suppl:
335
340
(
2016
).
19.
I. S.
Arty
,
R.
Arianingrum
and
S.
Atun
, “Sintesis Senyawa Mono Para Hidroksi Kalkon Bersubstituen Bromo dengan Katalis Asam dan Potensinya Sebagai Antioksidan”,
Prosiding Seminar Nasional dalam rangka Dies Natalis ke-49 Universitas Negeri Yogyakarta
,
LPPM UNY
,
2013
, pp.
478
48
20.
T.
Mosmann
,
J. Immunol Methods
,
65
,
55
63
(
1983
).
21.
A.
Doyle
and
J.B.
Griffith
,
Cell and tissue culture for medical research
,
New York
:
John Willey and Sons Ltd
. (
2000
).
22.
P.
Prayong
,
S.
Barusrux
,
N.
Weerapreeyakul
,
Fitoterapia
,
79
,
598
601
(
2008
).
23.
C.M.
Rudin
,
C.B.
Thompson
,
Annu Rev Med
,
48
:
267
281
(
1997
).
24.
R.
Simstein
,
M.
Burow
,
A.
Parker
,
C.
Weldon
and
B.
Beckman
,
Exp Biol Med
,
101
,
995
1003
(
2003
).
25.
V.R.
Yadav
,
S.
Prasad
,
B.
Sung
, and
B.B.
Anggarwal
,
International Immunopharmacology
,
11
(
3
),
295
309
(
2011
)
26.
H.L.
Pahl
,
Oncogene
,
18
(
49
),
6853
66
(
1999
).
This content is only available via PDF.
You do not currently have access to this content.